Tilray provides pharmaceutical-grade cannabis products to patients, researchers, pharmacies and governments. The Company cultivates and delivers the benefits of medical cannabis safely and reliably. It supplies products to patients, physicians, pharmacies, hospitals, governments and researchers in different countries.
TypePublic
HQNanaimo, CA
Founded2013
Size (employees)241 (est)
Websitetilray.com
Tilray was founded in 2013 and is headquartered in Nanaimo, CA
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Tilray

Brendan Kennedy

Brendan Kennedy

President, CEO
Mark Castaneda

Mark Castaneda

CFO, Secretary, Treasurer
Edward Wood Pastorius

Edward Wood Pastorius

Chief Revenue Officer
Josh Eades

Josh Eades

VP, Chief Scientific Officer
Christy Zhou

Christy Zhou

General Counsel
Adine Fabiani-Carter

Adine Fabiani-Carter

Chief Marketing Officer
Show more

Tilray Office Locations

Tilray has offices in Nanaimo, Berlin and Sydney
Nanaimo, (HQ)
1100 Maughan Rd
Sydney,
Gateway Tower Level 36, 1 Macquarie Place
Berlin,
1 Kemperpl.
Show all (3)
Report incorrect company information

Tilray Financials and Metrics

Tilray Revenue

Embed Graph
View revenue for all periods
Tilray's revenue was reported to be $20.54 m in FY, 2017 which is a 62.4% increase from the previous period.
USD

Revenue (Q2, 2018)

9.7m

Gross profit (Q2, 2018)

4.2m

Gross profit margin (Q2, 2018), %

42.9%

Net income (Q2, 2018)

(12.8m)

EBIT (Q2, 2018)

(11.0m)

Market capitalization (4-Dec-2018)

9.3b

Closing stock price (4-Dec-2018)

100.3

Cash (30-Jun-2018)

25.3m

EV

9.3b
Tilray's current market capitalization is $9.3 b.
Annual
USDFY, 2016FY, 2017

Revenue

12.6m20.5m

Revenue growth, %

62%

Cost of goods sold

10.0m9.2m

Gross profit

2.7m11.4m
Quarterly
USDQ1, 2017Q2, 2017Q1, 2018Q2, 2018

Revenue

5.0m5.0m7.8m9.7m

Cost of goods sold

2.3m2.3m3.9m5.6m

Gross profit

2.8m2.7m3.9m4.2m

Gross profit Margin, %

55%54%50%43%
Annual
USDFY, 2016FY, 2017

Cash

7.5m2.3m

Accounts Receivable

423.0k983.0k

Prepaid Expenses

71.0k545.0k

Inventories

4.1m7.4m
Quarterly
USDQ1, 2018Q2, 2018

Cash

12.1k25.3m

Accounts Receivable

1.1k1.8m

Prepaid Expenses

1.1k1.2m

Inventories

7.5k6.8m
Annual
USDFY, 2016FY, 2017

Net Income

(7.9m)(7.8m)

Depreciation and Amortization

2.0m1.9m

Inventories

693.0k(3.3m)

Accounts Payable

122.0k4.7m
Quarterly
USDQ1, 2017Q2, 2017Q1, 2018Q2, 2018

Net Income

(679.0k)(3.1m)(5.2m)(18.0m)

Depreciation and Amortization

545.0k955.0k479.0k1.1m

Inventories

(167.0k)(1.1m)(1.3m)48.0k

Accounts Payable

(15.0k)591.0k3.5m8.0m
USDY, 2018

EV/EBIT

-848.5 x

EV/CFO

-3.2 k x

Financial Leverage

3 x
Show all financial metrics

Tilray Operating Metrics

FY, 2016Q1, 2017FY, 2017Q1, 2018

Kilogram Equivalents Sold

2.22 k877 3.02 k1.30 k

Kilograms Harvested

4.53 k1.86 k6.78 k1.69 k

Average Net Selling Price per Gram

$5.41 $5.53 $6.52 $5.94

Average Cost per Gram Sold

$4.04 $2.48 $2.84 $2.81
Show all operating metrics

Tilray Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Dorada Ventures
Gatenhielm Group
High Park Farms, Ltd.
High Park Holdings, Ltd.
Pardal Holdings, Lda.
Tilray Australia New Zealand Pty. Ltd.
Tilray Canada
Tilray Deutschland GmbH
Tilray Portugal Unipessoal, Lda.

Tilray Revenue Breakdown

Embed Graph

Tilray revenue breakdown by business segment: 19.3% from Cannabis oils, 79.2% from Dried cannabis and 1.5% from Other

Tilray revenue breakdown by geographic segment: 96.3% from Canada and 3.7% from Other

Report incorrect company information

Tilray Online and Social Media Presence

Embed Graph
Report incorrect company information

Tilray News and Updates

IGC Resources and Westleaf Announce Closing of $20 Million Financing Including Investment from Tilray

Funding round includes $2.9 million strategic investment from Tilray, viewed as validating Westleaf’s strategy to roll-out its differentiated cannabis retail concept across Canada, focused on innovative retail experiences and engaging cannabis brands Funding round includes $2.9 million strategic inv…

Marijuana producer Tilray is sinking after a short seller announces he's targeting the company

Marijuana producer Tilray sank 2.7% after a hedge fund pitched its short position in the company on Monday.  Chris Brown, a partner at the long-short firm Aristides Capital, said marijuana is a "commodity business" and that the price of marijuana will "come down aggressively," at the Kase Learnin…

Thinking about buying stock in Aurora Cannabis Inc, Sphere 3D Corp, Arsanis, salesforce or Tilray Inc.?

NEW YORK, Nov. 28, 2018 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACB, ANY, ASNS, CRM, and TLRY. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Global Medical Cannabis Market Growth Forecast Up to 2025 Analysis By Companies like BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Canopy Growth Corporation, Insys Therapeutics, Inc., Medical Marijuana Inc.

Summary This report includes market status and forecast of global and major regions, with the introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Posted via Industry Today. Follow us on Twitter @Indu…

Tilray revenue doubled but losses widened ahead of legal pot sales in Canada

Tilray Inc. nearly doubled revenue as losses mounted ahead of Canadian legalization of recreational cannabis, the pot producer revealed Tuesday in an earnings report.

Stocks making the biggest moves after hours: Blue Apron, Tilray and more

See which stocks are posting big moves after the bell.
Show more
Report incorrect company information

Tilray Company Life and Culture

Report incorrect company information

Tilray Frequently Asked Questions

  • When was Tilray founded?

    Tilray was founded in 2013.

  • Who are Tilray key executives?

    Tilray's key executives are Brendan Kennedy, Mark Castaneda and Edward Wood Pastorius.

  • How many employees does Tilray have?

    Tilray has 241 employees.

  • What is Tilray revenue?

    Latest Tilray annual revenue is $20.5 m.

  • What is Tilray revenue per employee?

    Latest Tilray revenue per employee is $85.2 k.

  • Who are Tilray competitors?

    Competitors of Tilray include CV Sciences, Canndescent and Cronos Group.

  • Where is Tilray headquarters?

    Tilray headquarters is located at 1100 Maughan Rd, Nanaimo.

  • Where are Tilray offices?

    Tilray has offices in Nanaimo, Berlin and Sydney.

  • How many offices does Tilray have?

    Tilray has 3 offices.